Skip to content 
The fund will normally invest at least 80% of its net assets (including investment borrowings) in the securities that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking. It is non-diversified. more
| Time Frame | FTXH | S&P500 |
|---|---|---|
| 1-Week Return | -2.67% | 0.12% |
| 1-Month Return | 7.85% | 1.22% |
| 3-Month Return | 20.99% | 1.09% |
| 6-Month Return | 17.3% | 11.66% |
| 1-Year Return | 47.71% | 19.73% |
| 3-Year Return | 53.97% | 69.97% |
| 5-Year Return | 57.13% | 69.65% |
| 10-Year Return | 103.61% | 253.36% |
| Stock name | Ticker | Weight |
|---|---|---|
 Merck & Co., Inc. | MRK | 7.59% |
 Eli Lilly and Company | LLY | 7.05% |
 AbbVie Inc. | ABBV | 6.98% |
 Johnson & Johnson | JNJ | 6.84% |
 Bristol-Myers Squibb Company | BMY | 6.77% |
 Biogen Inc. | BIIB | 3.61% |
 Amgen Inc. | AMGN | 3.54% |
 Viatris Inc. | VTRS | 3.47% |
 Vertex Pharmaceuticals Incorporated | VRTX | 3.46% |
 Cardinal Health, Inc. | CAH | 3.25% |
 Regeneron Pharmaceuticals, Inc. | REGN | 3.23% |
 Pfizer Inc. | PFE | 3.2% |
 Gilead Sciences, Inc. | GILD | 3.1% |
 Incyte Corporation | INCY | 2.44% |
 United Therapeutics Corporation | UTHR | 2.42% |
 Jazz Pharmaceuticals Plc | JAZZ | 2.34% |
 Illumina, Inc. | ILMN | 2.27% |
 Zoetis Inc. | ZTS | 1.87% |
 Charles River Laboratories International, Inc. | CRL | 1.78% |
 Exelixis, Inc. | EXEL | 1.61% |
 Halozyme Therapeutics, Inc. | HALO | 1.51% |
 Medpace Holdings, Inc. | MEDP | 1.48% |
 Twist Bioscience Corporation | TWST | 1.31% |
 BioMarin Pharmaceutical Inc. | BMRN | 1.17% |
 10X Genomics, Inc. (Class A) | TXG | 1.16% |
 Neurocrine Biosciences, Inc. | NBIX | 1.16% |
 Alkermes Plc | ALKS | 1.14% |
 Moderna, Inc. | MRNA | 1.12% |
 PTC Therapeutics, Inc. | PTCT | 1.1% |
 Travere Therapeutics, Inc. | TVTX | 0.96% |
 Spyre Therapeutics, Inc. | SYRE | 0.91% |
 TG Therapeutics, Inc. | TGTX | 0.78% |
 Elanco Animal Health Incorporated | ELAN | 0.76% |
 Guardant Health, Inc. | GH | 0.75% |
 Protagonist Therapeutics, Inc. | PTGX | 0.68% |
 Amneal Pharmaceuticals, Inc. | AMRX | 0.65% |
 Arrowhead Pharmaceuticals, Inc. | ARWR | 0.64% |
 Arcus Biosciences, Inc. | RCUS | 0.63% |
 Ligand Pharmaceuticals Inc. (Class B) | LGND | 0.61% |
 Kymera Therapeutics, Inc. | KYMR | 0.57% |
 Krystal Biotech, Inc. | KRYS | 0.56% |
 Roivant Sciences Ltd. | ROIV | 0.52% |
 ACADIA Pharmaceuticals Inc. | ACAD | 0.52% |
 Mirum Pharmaceuticals, Inc. | MIRM | 0.46% |
 Tarsus Pharmaceuticals, Inc. | TARS | 0.41% |
 Arcutis Biotherapeutics, Inc. | ARQT | 0.38% |
 Supernus Pharmaceuticals, Inc. | SUPN | 0.35% |
 Ionis Pharmaceuticals, Inc. | IONS | 0.33% |
 Alnylam Pharmaceuticals, Inc. | ALNY | 0.31% |
 US Dollar | US.Dollar | 0.24% |
| Sector | Weight |
|---|---|
|
Health care | 100.00% |
First Trust Nasdaq Pharmaceuticals ETF (FTXH) share price today is $41.6177.
Yes, Indians can buy shares of First Trust Nasdaq Pharmaceuticals ETF (FTXH) on Vested. To buy FTXH from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of First Trust Nasdaq Pharmaceuticals ETF (FTXH) on Vested. You can start investing in First Trust Nasdaq Pharmaceuticals ETF (FTXH) with a minimum investment of $1.
The 52-week high price of First Trust Nasdaq Pharmaceuticals ETF (FTXH) is $42.87. The 52-week low price of First Trust Nasdaq Pharmaceuticals ETF (FTXH) is $27.08.
The stock symbol (or ticker) of First Trust Nasdaq Pharmaceuticals ETF is FTXH.
Yes, you can setup SIP in First Trust Nasdaq Pharmaceuticals ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of FTXH on the Vested app.
The expense ratio of First Trust Nasdaq Pharmaceuticals ETF (FTXH) is 0.6%.
Link copied 
